Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Mary Ann Liebert, Inc. Submission Benefits Package
Your submission to Telemedicine and e-Health provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive:
- Rapid, rigorous peer-review and editorial attention
- Immediate deposit to PubMed and other indexing services upon online publication
- Exposure to thousands of thought-leaders in your field, maximizing readers, citations, and downloads
- Fast Track online-ahead-of-print publication
- Global availability in over 170 countries
- Open Access publication options
Submitting Your Manuscript
Submitting your manuscript to Telemedicine and e-Health delivers a comprehensive benefits program that ensures high-quality review of your research and maximum impact for your work. Telemedicine and e-Health carries a manuscript processing charge* of $49.00 USD upon submission of each new manuscript.
Upon payment, you will be provided a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system. Please note: Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission.
Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges.
Click here to submit your paper via our fast and user-friendly electronic submission system.
Processing charges and submission codes are NOT required for revisions to previously submitted papers. To upload a revision of a paper, the submitting author should log in to their Author Center at http://mc.manuscriptcentral.com/telemedicine and click on “Revised Manuscripts in Draft.” The paper will appear in this area, and the submitting author will be able to upload revised files without paying any charges or entering a submission code.
Please be sure to follow the Instructions for Authors below on Manuscript Preparation. Authors whose submissions do not comply with the Instructions for Authors will have their papers un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time the paper is un-submitted. The submitting author/agent will then be provided the opportunity to re-upload the corrected file(s). If a paper is un-submitted, the paper will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments and re-upload the paper without incurring another manuscript processing charge.
*The manuscript processing charge is independent of editorial decision and is non-refundable.
PREPARATION OF MANUSCRIPT
Original Research Papers: The title page should include the authors' names and affiliations, the source of a work or study (if any), and a running title of about 45 characters. Please indicate the author to whom correspondence should be sent when you submit. The abstract should not be more than 250 words and should be self-explanatory without reference to the text. Abstracts should contain separate sections as follows: Background, Introduction, Materials and Methods, Results, Discussion, and Conclusions. Abstracts for perspective papers should not have these separate sections. Papers should follow this format: Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References. The body of the MS should not exceed 3000 words. Number pages consecutively. At the end of the paper, give the name and address of the individual to whom reprint requests should be directed.
An abstract of 250 words should outline the purpose, methodology and results of the communication. The format for the body of the MS may vary depending upon the nature of the report but may not exceed 1000 words. References should be included and style instructions below apply.
An abstract of 250 words should state the subject of the review and its importance. The abstract should summarize the most important points of the review. The body of the MS should take on headings appropriate for the topic (for example Introduction, Technology Issues, Regulatory Issues, Clinical Studies, Future Events). The body of the manuscript should not exceed 3000 words. The style instructions are below.
The Journal accepts “Opinion” papers subject to editorial and peer review. These papers are dedicated to the opinion of the writer and should have relevance to telemedicine and e-health and be supported by references. They are not reviews but reflect proposals or considerations of matters that might encourage the readers to anticipate a new area of telemedicine, a current issue in telemedicine, or even a look back at some matter of historical importance. The submissions are limited to 1,000 words.
The editors welcome letters concerning items published in the journal. Book reviews and potential news items are also welcome. These items should be submitted online via our peer review system (https://mc.manuscriptcentral.com/telemedicine).
Please adhere to correct formatting requirements to avoid delays in publication.
Patient Release Information
If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients, and to retain this documentation as part of their files. The submitting author should provide written confirmation of this critical information. Acceptable forms of consent statements are emails, letters, or internal institutional forms. The Journal does not provide a generic patient release form.
The written consent must contain specific information about the patient's name, age, and if pertinent, conservatorship -- as well as stated permission -- granting the Journal the rights to publish the photograph within its pages. Such permission should include the name of the Journal and article title.
CREATE AN EFFECTIVE TITLE:
- Manuscript titles should be brief, contain key terms, and clearly identify the purpose of the work conducted
- Titles should be no more than 12-15 words
- Titles should be direct and to the point. Remember that the journal has a global readership, so clear and concise non-vernacular language is most effective
- Avoid the use of specific locations in the title
- Do not use proprietary/trademarked names in the title
- Do not use acronyms in the title unless they are universally recognized and accepted
Tables should be prepared in Microsoft Word. All tables should be supplied in a separate continuous file, and should NOT be part of or embedded in the main manuscript file.
Use Arabic numerals to consecutively number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. Provide a title for each table. Define all acronyms in table footnotes. All other types of table footnotes should be designated using superscripted letters, not symbols.
Electronic submission of art MUST follow these guidelines:
- Do not embed any illustrations as part of your text file.
- Each figure must be supplied separately.
- Please submit only TIFF or EPS files.
- Do not prepare any figures in Word as they are not workable.
- Line illustrations must be submitted at 900 DPI.
- Halftones and color photos should be submitted at 300 DPI.
- Color art must be saved as CYMK not RGB or INDEX. If RGB files are submitted, the files will be converted to CYMK, and some color variation may occur.
- Do NOT submit PowerPoint or Excel files. Adobe is the software of choice.
When naming your figure files, please name them with the author's last name, followed by the figure number. (Ex: SmithFig1). Avoid using punctuation or special characters.
Color illustrations are welcome, but the author must subsidize the cost of color printing. The Publisher will provide the author with a cost estimate when the figures are received. Please contact our Author Benefits Program for more information.
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance.
If no conflicts exist, the authors must state “No competing financial interests exist."
Reference citations are not permitted in the abstract of a paper. References should be presented in the following style: Journal paper: Murphy RL, Bird KT. Tele-diagnosis: a new community health resource. Observations on the feasibility of tele-diagnosis based on 1000 patient transactions. Am J Public Health 1974;64:113-119 Book: Conrath DW, Dunn EV, Higgins CA. Evaluating telecommunications technology in medicine. Dedham MA Artech House, 1983: 20 24 Chapter in a Book: Park B. Communications aspects of telemedicine. In: Bashshur RL, Armstrong PA, Youssef Zl, eds. Telemedicine: explorations in the use of telecommunications in health care. Springfield IL: Charles Thomas, 1975: 54-88. If it is necessary to cite an abstract, this should be so designated. Authors are responsible for the accuracy of the reference and are reminded that inaccurate references are highly frustrating to the reader, the cited author, and indexing services. Abbreviations of journal titles should follow Medline.
Follow the Uniform Guidelines for manuscripts submitted to biomedical journals (Ann Intern Med 1988; 108:258-265). Papers will be edited to conform to the individual style of Telemedicine and e-Health.
Please upload individual files of all manuscript material — do NOT upload a single file containing all text, figure, and table files of your paper. Text and tables should be submitted in Microsoft Word format. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
The author must obtain permission to reproduce figures, tables, and text from previously published material, even if that is the author's own work. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material cited from other institutions and should accompany the manuscript.
USE OF APPLICATION NAMES and IMAGES
The registered (®) or trademark (™) symbol must appear at the first mention of any product or app in the abstract and then again at the first mention in text, table, as well as in any figure and/or table legends/keys in which the application name is used.
If any images and/or screenshots of proprietary logos are included in the manuscript, written permission must be secured (by the authors) from the copyright holder of the application.
CONFLICTS OF INTEREST
All authors must disclose any associations that pose real or perceived conflicts of interest in connection with the manuscript. Authors must acknowledge all funding sources supporting the work. Authors should also disclose any financial interests that they may have in the company supporting the work.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
Telemedicine and e-Health publishes 12 issues annually by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2101.
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.org.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.